Cachexia Index in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis
- PMID: 38676902
- DOI: 10.1007/s12029-024-01055-1
Cachexia Index in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis
Abstract
Purpose: The cachexia index is a novel biomarker of cancer cachexia. This systematic review and meta-analysis aimed to evaluate the prognostic impact of cachexia index on prognosis after surgery for gastrointestinal cancer.
Methods: In August 2023, we systematically searched PubMed, the Cochrane Library, and Ovid for relevant studies on the oncological outcome after gastrointestinal cancer surgery and analyzed the findings from these studies for meta-analysis.
Results: Our systematic and meta-analysis review identified eight studies involving 1876 patients. The number of patients with low cachexia index accounted for 813 patients (43.3%). We found that low cachexia index was associated with worse overall survival (pooled HR, 2.30; 95% CI, 1.85-2.87; z = 7.49; P < 0.001) and disease/relapse/progression-free survival (pooled HR, 1.77; 95% CI, 1.45-2.18; z = 5.50; P < 0.001).
Conclusion: Our meta-analysis showed that cachexia index was associated with oncological outcome after gastrointestinal cancer surgery. However, the limitations of this meta-analysis should be taken into consideration when interpreting the results.
Keywords: Cachexia index; Gastrointestinal cancer; Meta-analysis; Survival.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Skeletal Muscle Index-Based Cachexia Index as a Predictor of Prognosis in Patients With Cancer: A Meta-Analysis and Systematic Review.Nutr Rev. 2025 Mar 1;83(3):e852-e865. doi: 10.1093/nutrit/nuae094. Nutr Rev. 2025. PMID: 39001797
-
The advanced lung cancer inflammation index is a prognostic factor for gastrointestinal cancer patients undergoing surgery: a systematic review and meta-analysis.World J Surg Oncol. 2023 Mar 6;21(1):81. doi: 10.1186/s12957-023-02972-4. World J Surg Oncol. 2023. PMID: 36879283 Free PMC article.
-
Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery.J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):891-902. doi: 10.1002/jcsm.13207. Epub 2023 Mar 7. J Cachexia Sarcopenia Muscle. 2023. PMID: 36880286 Free PMC article.
-
A novel tissue inhibitor of metalloproteinases-1/liver/cachexia score predicts prognosis of gastrointestinal cancer patients.J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):378-392. doi: 10.1002/jcsm.12680. Epub 2021 Feb 16. J Cachexia Sarcopenia Muscle. 2021. PMID: 33590974 Free PMC article.
-
Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery.Surg Today. 2023 Sep;53(9):1064-1072. doi: 10.1007/s00595-023-02646-4. Epub 2023 Feb 1. Surg Today. 2023. PMID: 36725756